130 related articles for article (PubMed ID: 21755533)
21. The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections.
Warnke PH; Becker ST; Podschun R; Sivananthan S; Springer IN; Russo PA; Wiltfang J; Fickenscher H; Sherry E
J Craniomaxillofac Surg; 2009 Oct; 37(7):392-7. PubMed ID: 19473851
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Romano L; Battaglia F; Masucci L; Sanguinetti M; Posteraro B; Plotti G; Zanetti S; Fadda G
J Antimicrob Chemother; 2005 Jan; 55(1):110-4. PubMed ID: 15574476
[TBL] [Abstract][Full Text] [Related]
23. Antimycotic effect of the essential oil of Aloysia triphylla against Candida species obtained from human pathologies.
Oliva Mde L; Carezzano ME; Gallucci MN; Demo MS
Nat Prod Commun; 2011 Jul; 6(7):1039-43. PubMed ID: 21834253
[TBL] [Abstract][Full Text] [Related]
24. Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function.
Sharma Y; Khan LA; Manzoor N
J Mycol Med; 2016 Sep; 26(3):244-54. PubMed ID: 27554866
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of essential oil from Ocimum gratissimum L. against four Candida species.
Nakamura CV; Ishida K; Faccin LC; Filho BP; Cortez DA; Rozental S; de Souza W; Ueda-Nakamura T
Res Microbiol; 2004 Sep; 155(7):579-86. PubMed ID: 15313260
[TBL] [Abstract][Full Text] [Related]
26. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
27. Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro.
Gowri M; Jayashree B; Jeyakanthan J; Girija EK
J Appl Microbiol; 2020 Feb; 128(2):426-437. PubMed ID: 31621139
[TBL] [Abstract][Full Text] [Related]
28. Lichen endophyte derived pyridoxatin inactivates Candida growth by interfering with ergosterol biosynthesis.
Chang W; Zhang M; Li Y; Li X; Gao Y; Xie Z; Lou H
Biochim Biophys Acta; 2015 Sep; 1850(9):1762-71. PubMed ID: 25960388
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
31. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
33. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of the essential oil of Thymus x viciosoi against Candida, Cryptococcus, Aspergillus and dermatophyte species.
Vale-Silva LA; Gonçalves MJ; Cavaleiro C; Salgueiro L; Pinto E
Planta Med; 2010 Jun; 76(9):882-8. PubMed ID: 20104443
[TBL] [Abstract][Full Text] [Related]
35. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
37. Potential of plant oils as inhibitors of Candida albicans growth.
Devkatte AN; Zore GB; Karuppayil SM
FEMS Yeast Res; 2005 Jun; 5(9):867-73. PubMed ID: 15925315
[TBL] [Abstract][Full Text] [Related]
38. The effect of Leptospermum petersonii essential oil on Candida albicans and Aspergillus fumigatus.
Hood JR; Burton DM; Wilkinson JM; Cavanagh HM
Med Mycol; 2010 Nov; 48(7):922-31. PubMed ID: 20446888
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of the activity of an essential oil from Pistacia vera L. variety Bronte hull against Candida sp.
D'Arrigo M; Bisignano C; Irrera P; Smeriglio A; Zagami R; Trombetta D; Romeo O; Mandalari G
BMC Complement Altern Med; 2019 Jan; 19(1):6. PubMed ID: 30612544
[TBL] [Abstract][Full Text] [Related]
40. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
